Longitudinal resting‐state EEG along the Alzheimer’s disease continuum: Sample size considerations for clinical trials
Background To enable successful inclusion of resting‐state electroencephalography (EEG) outcome measures in Alzheimer’s disease (AD) clinical trials, we (retrospectively) mapped the progression of EEG markers over time in amyloid‐positive subjects. Methods Resting‐state 21‐channel EEG was recorded i...
Saved in:
Published in | Alzheimer's & dementia Vol. 19; no. S21 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
01.12.2023
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!